Exact Sciences Corporation - Common Stock (NQ:EXAS)

104.91 UNCHANGED

Last Price Updated: 4:00 PM EDT, Mar 20, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Exact Sciences Corporation - Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

23 24 Next >

3 of Wall Street’s Favorite Stocks We’re Skeptical Of

August 29, 2025

The stocks in this article have caught Wall Street’s attention in a big way, with price targets implying returns above 20%. But investors should take these forecasts with a grain of salt because...

Via StockStory

Exact Sciences to Participate in September Investor Conferences

August 19, 2025

From Exact Sciences Corp.

Via Business Wire

3 Unprofitable Stocks We Think Twice About

August 18, 2025

Unprofitable companies can burn through cash quickly, leaving investors exposed if they fail to turn things around. Without a clear path to profitability, these businesses risk running out of capital...

Via StockStory

Sotera Health Company, Incyte, Exact Sciences, Bausch + Lomb, and Addus HomeCare Shares Skyrocket, What You Need To Know

August 13, 2025

A number of stocks jumped in the afternoon session after markets continued to rally amid growing speculation of an impending interest rate cut by the Federal Reserve. Following a favorable Consumer...

Via StockStory

Topics Economy Lawsuit

1 Small-Cap Stock to Own for Decades and 2 We Turn Down

August 13, 2025

Many small-cap stocks have limited Wall Street coverage, giving savvy investors the chance to act before everyone else catches on. But the flip side is that these businesses have increased downside...

Via StockStory

Micron To Rally More Than 49%? Here Are 10 Top Analyst Forecasts For Tuesday ↗

August 12, 2025

Via Benzinga

EXAS Q2 Deep Dive: Portfolio Expansion and Productivity Drive Guidance Increase Amid Market Caution

August 12, 2025

Diagnostic company Exact Sciences Corporation (NASDAQ:EXAS) announced better-than-expected revenue in Q2 CY2025, with sales up 16% year on year to $811.1 million. The company’s full-year revenue...

Via StockStory

Earnings Scheduled For August 6, 2025 ↗

August 06, 2025

Via Benzinga

An Overview of Exact Sciences's Earnings ↗

August 05, 2025

Via Benzinga

3 Out-of-Favor Stocks We Steer Clear Of

August 12, 2025

Hitting a new 52-week low can be a pivotal moment for any stock. These floors often mark either the beginning of a turnaround story or confirmation that a company faces serious headwinds.

Via StockStory

Topics Supply Chain

Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought ↗

August 11, 2025

The rock-star money manager is making the most of sell-offs in some of her stocks.

Via The Motley Fool

Beyond The Numbers: 7 Analysts Discuss Exact Sciences Stock ↗

August 11, 2025

Via Benzinga

Top 3 Health Care Stocks That Are Preparing To Pump This Month ↗

August 11, 2025

Via Benzinga

Exact Sciences Dip A Chance To Buy As Freenome Deal Fortifies Future: Analyst ↗

August 07, 2025

Exact Sciences beat Q2 expectations, raised its 2025 forecast, and secured U.S. rights to Freenome's CRC blood tests in a major strategic move.

Via Benzinga

Discover the top movers in Thursday's pre-market session. ↗

August 07, 2025

The US market is yet to commence its session on Thursday, but let's get a preview of the pre-market session and explore the top gainers and losers driving the early market movements.

Via Chartmill

Redwire Posts Downbeat Q2 Results, Joins Tandem Diabetes Care, Fortinet, Symbotic And Other Big Stocks Moving Lower In Thursday's Pre-Market Session ↗

August 07, 2025

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

August 07, 2025

Via Benzinga

Why Groupon Shares Are Trading Higher By Around 28%; Here Are 20 Stocks Moving Premarket ↗

August 07, 2025

Via Benzinga

Exact Sciences (NASDAQ:EXAS) Reports Strong Q2 But Stock Drops 15.2%

August 06, 2025

Diagnostic company Exact Sciences Corporation (NASDAQ:EXAS) reported Q2 CY2025 results exceeding the market’s revenue expectations, with sales up 16% year on year to $811.1 million. The company’s...

Via StockStory

Exact Sciences (EXAS) Q2 Revenue Up 16% ↗

August 06, 2025

Via The Motley Fool

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

August 06, 2025

Via Benzinga

Stay updated with the stocks that are on the move in today's after-hours session. ↗

August 06, 2025

Let's have a look at what is happening on the US markets after the closing bell on Wednesday. Below you can find the top gainers and losers in today's after hours session.

Via Chartmill

How Exact Sciences Is Spending $775 Million To Dominate The Cancer-Screening Market ↗

August 06, 2025

The company is expanding its oncology efforts with a deal for a blood-based colorectal cancer screening test.

Via Investor's Business Daily

Topics Earnings

Exact Sciences Announces Second Quarter 2025 Results

August 06, 2025

From Exact Sciences Corp.

Via Business Wire

Exact Sciences Announces Exclusive License with Freenome for Blood-Based Colorectal Cancer Screening Tests

August 06, 2025

From Exact Sciences Corp.

Via Business Wire

Exact Sciences (EXAS) To Report Earnings Tomorrow: Here Is What To Expect

August 04, 2025

Diagnostic company Exact Sciences Corporation (NASDAQ:EXAS) will be reporting earnings this Wednesday after market close. Here’s what to expect.

Via StockStory

Topics World Trade

Exact Sciences and Humana Expand Colorectal Cancer Screening Partnership with Cologuard Plus™ Test

July 31, 2025

From Exact Sciences Corp.

Via Business Wire

3 Cash-Producing Stocks We Find Risky

July 28, 2025

Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it effectively, leading to missed opportunities.

Via StockStory

Thermo Fisher, Exact Sciences, Integer Holdings, Revvity, and 10x Genomics Shares Are Falling, What You Need To Know

July 18, 2025

A number of healthcare stocks fell in the afternoon session after several negative developments weighed on the sector. Weakness in managed care providers was a significant factor, with companies like...

Via StockStory

Topics Lawsuit World Trade

Exact Sciences Schedules Second Quarter 2025 Earnings Call

July 14, 2025

From Exact Sciences Corp.

Via Business Wire

< Previous 1 2 3 4 5 6 7 8 9

...

23 24 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.